In comparison with the CON-HCC group, tumors in PEDF-HCC group exhibited persistent increased FASN levels, as well as decreased CPT1α and pAMPK levels (Fig. 5k). The gene discussed is CPT1A; the disease is hepatocellular carcinoma.